MyMD Pharmaceuticals, Inc. (MYMD)

NASDAQ: MYMD · IEX Real-Time Price · USD

1.860

-0.120 (-6.06%)

At close: May 31, 2024, 4:00 PM

1.810

-0.050 (-2.69%)

After-hours: May 31, 2024, 7:36 PM EDT

MyMD Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Selling, General & Admin	5.44	5.52	6.42	2.95	3.4	Upgrade
Research & Development	7.87	9.07	6.75	2.47	0	Upgrade
Other Operating Expenses	3.05	0.7	15.04	2.88	0.08	Upgrade
Operating Expenses	16.36	15.28	28.2	8.3	3.47	Upgrade
Operating Income	-16.36	-15.28	-28.2	-8.3	-3.47	Upgrade
Other Expense / Income	-12.36	-0.09	1.69	1.19	0.42	Upgrade
Pretax Income	-4	-15.2	-29.89	-9.49	-3.89	Upgrade
Net Income	-4	-15.2	-29.89	-9.49	-3.89	Upgrade
Preferred Dividends	4.22	0	0	0	0	Upgrade
Net Income Common	-8.22	-15.2	-29.89	-9.49	-3.89	Upgrade
Shares Outstanding (Basic)	2	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	1	0	Upgrade
Shares Change	19.18%	10.88%	24.23%	9101.99%	25.81%	Upgrade
EPS (Basic)	-5.33	-11.74	-25.50	-10.20	-381.00	Upgrade
EPS (Diluted)	-5.33	-11.74	-25.50	-10.20	-381.00	Upgrade
Free Cash Flow	-12.98	-12.27	-19.52	-4.66	-3.07	Upgrade
Free Cash Flow Per Share	-8.42	-9.48	-16.72	-4.96	-300.46	Upgrade
EBITDA	-4	-15.2	-29.89	-9.47	-3.81	Upgrade
Depreciation & Amortization	0	0	0	0.02	0.07	Upgrade
EBIT	-4	-15.2	-29.89	-9.49	-3.89	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).